Hims vs Trimi for GLP-1 Weight Loss: An Honest Comparison
Hims vs Trimi semaglutide in 2026: Hims' announced brand-name Wegovy access and separate membership vs Trimi's compounded semaglutide (not FDA-approved). Pharmacy, clinicians and costs compared.
More on GLP-1 Provider Comparisons
Overview: Two Different Approaches to GLP-1 Access
The telehealth landscape for GLP-1 weight loss medications has expanded rapidly, and patients now have more options than ever for accessing semaglutide and tirzepatide online. Two platforms that frequently come up in patient research are Hims and Trimi, but they take notably different approaches to the same fundamental goal of making GLP-1 therapy accessible and affordable.
Hims, formally known as Hims & Hers Health, is a large publicly traded telehealth company that started in 2017 with a focus on men's health products including hair loss and erectile dysfunction treatments. Over time, the company expanded into dozens of health categories for both men and women, including skincare, mental health, sexual health, and more recently, weight loss. Their GLP-1 program is one vertical within a broad consumer health platform that serves millions of customers across many different treatment areas.
Trimi, by contrast, was built from the ground up specifically around GLP-1 weight loss therapy. Every aspect of the platform, from the health assessment to provider matching, dosing protocols, and ongoing support, is designed with metabolic health and weight management as the core focus. This difference in origin and focus shapes nearly every aspect of the patient experience, from how consultations are conducted to how medication is sourced and priced.
In this comparison, we will examine both platforms honestly and in detail. Both are legitimate telehealth services with real providers and real medications. The question is not which one is "real", both are, but rather which one is the better fit for your specific needs, budget, and treatment goals when it comes to semaglutide or tirzepatide therapy.
Pricing Comparison: What You Actually Pay
Cost is typically the most important factor for patients choosing a GLP-1 provider, and it adds up over a treatment course that may last months or years. Understanding the full cost picture, not just the advertised starting price, is essential for making a sound financial decision about your weight loss treatment.
In a March 2026 announcement, Hims said medication is billed separately from its required Weight Loss Membership, and that its providers can prescribe brand-name Wegovy and Ozempic. We could not confirm Hims' per-medication prices on hims.com in October 2026; check Hims' current weight-loss pricing page for medication costs and membership fees. Prices change frequently, and promotional pricing may apply to initial months.
Trimi takes a transparent, straightforward approach to pricing that focuses specifically on keeping GLP-1 medications affordable. Trimi offers compounded semaglutide and tirzepatide options, which are not FDA-approved, with clear published pricing: compounded semaglutide is $99 per month on the annual plan, a 12-month commitment, or $175 on the month-to-month plan.
Pricing Note
Telehealth pricing for GLP-1 medications changes frequently. The figures mentioned here are approximate and based on publicly available information at the time of writing. Always verify current pricing directly on each platform before making a decision.
Medication Options and Sourcing
The type and quality of medication you receive is a critical factor in any GLP-1 program. Hims and Trimi differ in what they offer and how medications are sourced, in ways that patients should understand before committing to either platform.
In March 2026 announcements, Hims said it would no longer advertise compounded GLP-1 offerings and that its providers can prescribe Wegovy pills, Wegovy injections and Ozempic injections; in April 2026, it said its providers can also send Zepbound and Foundayo prescriptions to the LillyDirect pharmacy. In its August 2026 SEC earnings release, Hims said it offers access to compounded GLP-1 medications on a limited scale.
Trimi works with a vetted, state-licensed 503A community sterile-compounding pharmacy that meets stringent quality standards. Every compounded medication dispensed through Trimi undergoes potency and sterility testing. Trimi offers both compounded semaglutide and compounded tirzepatide, providing patients and providers with flexibility to choose the GLP-1 medication that best matches their clinical profile. This dual-medication approach is an advantage for patients who may respond better to one molecule than the other, or who may need to switch during their treatment course.
For patients specifically interested in brand-name Ozempic, Wegovy, or Zepbound, Hims has said its providers can prescribe them. Trimi offers compounded preparations instead, which follow a different regulatory pathway and are not FDA-approved as drugs. Understanding the true cost of semaglutide across all channels can help you determine which approach makes the most financial sense.
Provider Quality and Clinical Expertise
The quality of your prescribing provider matters enormously in GLP-1 therapy. Proper dose titration, side effect management, and clinical monitoring can be the difference between a successful weight loss outcome and an uncomfortable or even unsafe experience. How each platform approaches provider selection and clinical oversight shapes the quality of care you receive throughout your treatment.
Hims operates across several health categories. That company-level breadth does not establish the specialty or GLP-1 experience of the clinician assigned to an individual patient. Ask Hims about provider credentials and how ongoing care is handled.
Trimi's provider network is composed of board-certified providers and nurse practitioners who focus specifically on metabolic health and GLP-1 therapy. Because Trimi does not offer dozens of unrelated health categories, the providers on the platform develop deep expertise in weight management pharmacology. They are experienced with the specific challenges of GLP-1 dose titration, recognizing when to slow escalation due to side effects, when to hold a dose, and when to advance. This specialized focus often translates into more nuanced clinical guidance during your treatment course.
Confirm each platform's current intake and consultation options before enrolling. Follow-up communication models vary, patients should understand how each platform handles ongoing questions, side effect concerns, and dose adjustments throughout treatment. Trimi offers direct messaging with your care team for ongoing support and clinical questions. Learn more about the process of getting GLP-1 prescribed online.
Turnaround Time and Shipping
When you decide to start GLP-1 therapy, waiting weeks for your first dose can be frustrating and may undermine the momentum of your decision to pursue treatment. The time from initial sign-up to medication in hand varies meaningfully between platforms, and understanding these timelines can help set appropriate expectations.
On Hims, the process typically involves completing an online assessment, waiting for provider review, and then waiting for pharmacy fulfillment and shipping. For Hims' current timelines, check with Hims directly.
Trimi is designed for speed without sacrificing clinical thoroughness. Most patients complete their health assessment in under 15 minutes, and a provider typically reviews and responds within 12–24 hours. Once approved, medication is shipped directly from the compounding pharmacy with cold-chain packaging to maintain medication integrity. Many patients receive their medication within days of provider approval.
Ongoing Support and Patient Experience
GLP-1 therapy is not a one-time prescription, it is an ongoing treatment that typically requires months of dose titration, side effect management, and lifestyle adjustments. The quality of ongoing support you receive throughout this process can significantly impact both your clinical outcomes and your overall experience as a patient.
Ask Hims how to contact the care team for follow-up questions, side effects or dose adjustments, and confirm the available communication options before enrolling.
Trimi's approach to ongoing support reflects its focused mission. Patients have access to their care team for questions about side effects, dosing, injection technique, and treatment planning. Because Trimi's providers work exclusively in the GLP-1 and weight management space, the support interactions tend to be more specific and clinically targeted. Patients dealing with common GLP-1 challenges, such as semaglutide side effects like nausea or constipation, can receive guidance from providers who manage these issues daily across their entire patient panel.
For patients who value a more personal clinical relationship and direct access to a provider who specializes in their specific treatment, the focused telehealth model that Trimi offers can be a meaningful advantage. For patients who prefer the comprehensive ecosystem of a larger platform and may want to manage multiple health needs in one place, Hims' breadth may be appealing.
Pros and Cons: Side by Side
To help you make a clear decision, here is an honest assessment of the strengths and limitations of each platform for GLP-1 weight loss therapy.
Hims: Strengths
Established, publicly traded company with a long track record in telehealth since 2017
Broad platform that allows you to manage multiple health conditions in one place
Large provider network that typically means quick initial matching with a clinician
Strong brand recognition and widely reviewed by patients across the internet
Subscription model may appeal to patients who prefer predictable billing structures
Hims: Limitations
GLP-1 is one of many product categories, providers may not specialize exclusively in weight management
Some patients report inconsistent follow-up communication and difficulty reaching their provider
Promotional pricing structures can make it harder to predict long-term costs
Trimi: Strengths
Purpose-built for GLP-1 weight loss, every feature is designed around this treatment
Board-certified providers who specialize in metabolic health and GLP-1 therapy
Transparent, published plan pricing for compounded semaglutide and tirzepatide
Offers both compounded semaglutide and tirzepatide for clinical flexibility
Fast turnaround from assessment to medication delivery, often within days of approval
Direct access to your care team for ongoing support and clinical questions
Trimi: Limitations
Newer platform compared to the established Hims brand with less brand recognition
Focused exclusively on GLP-1 therapy, not a one-stop shop for other health needs
Does not offer brand-name GLP-1 medications (focuses on compounded formulations)
Who Should Choose Hims vs. Trimi?
The best platform for you depends on what you value most in a healthcare provider relationship and what your specific treatment needs are. Neither platform is universally better, they serve somewhat different patient profiles and priorities.
Hims may be the better fit if you already use the Hims platform for other health needs and value having everything in one place, if brand recognition and the track record of a publicly traded company are important to you, or if you are looking for a general telehealth relationship that extends beyond weight management into other health areas. Hims' broad platform can be convenient for patients who want a single login for multiple health needs.
Trimi may be the better fit if you want transparent pricing for compounded GLP-1 medications, which are not FDA-approved, if you want a provider who specializes specifically in GLP-1 therapy and metabolic health rather than a generalist, if you want the option to choose between semaglutide and tirzepatide based on your clinical needs, or if fast turnaround from consultation to medication is important to you. Trimi's focused approach typically translates to more specialized care for GLP-1 therapy specifically.
Regardless of which platform you choose, the most important thing is that you are working with a licensed provider who can properly evaluate your health history, prescribe an appropriate starting dose, guide your titration, and monitor your progress. Both Hims and Trimi meet this fundamental standard. For the full pricing comparison across all major providers including Ro, Found, Mochi, Henry Meds, and LillyDirect, see our cheapest legal GLP-1 online cornerstone; for a comprehensive understanding of GLP-1 medications before choosing a provider, review our complete GLP-1 guide.
Understanding Compounded GLP-1 Medications
Trimi offers compounded versions of GLP-1 medications rather than brand-name products like Ozempic or Wegovy, which Hims has said its providers can prescribe. Understanding what compounded medications are and how they work is important context for any platform comparison in this space.
Compounded semaglutide and tirzepatide are prepared by state-licensed compounding pharmacies against an individual prescription rather than manufactured as FDA-approved finished drugs, and they have not been studied in their own clinical trials. Compounding pharmacies must meet strict quality standards set by their state boards and USP sterile-compounding chapters.
For a deeper understanding of the safety considerations around compounded GLP-1 medications, including how to verify pharmacy credentials and what quality testing to expect, review our detailed analysis of compounded semaglutide safety in 2026. Both platforms should be able to provide information about their pharmacy partners upon request.
Frequently Asked Questions
Does Hims prescribe semaglutide for weight loss?
Yes. In March 2026 announcements, Hims said its providers can prescribe Wegovy pills, Wegovy injections and Ozempic injections, and that it would no longer advertise compounded GLP-1 offerings; its August 2026 SEC earnings release says it offers access to compounded GLP-1 medications on a limited scale. Their platform connects patients with licensed providers who can evaluate eligibility and prescribe GLP-1 medications. Hims has expanded significantly from its original focus on men's health into weight management, offering both oral and injectable options depending on availability and provider recommendation.
How does Trimi's pricing compare to Hims for GLP-1 medications?
In a March 2026 announcement, Hims said its required Weight Loss Membership is billed separately from medication, and we could not confirm Hims' per-medication prices on hims.com in October 2026. Trimi offers compounded GLP-1 medications, which are not FDA-approved, with published plan pricing. Both platforms' prices may vary, so it is worth checking current rates on each website directly.
Is Hims legitimate for weight loss medications?
Yes, Hims is a legitimate, publicly traded telehealth company (NYSE: HIMS) that operates with licensed healthcare providers and partners with licensed pharmacies. They have been in the telehealth space since 2017 and have served millions of patients across various health categories. Their weight loss program is a newer addition to their platform, and the providers who prescribe through Hims are licensed in the states where they practice.
Can I switch from Hims to Trimi for my GLP-1 medication?
Yes, switching from Hims to Trimi is straightforward. You would complete Trimi's online health assessment, and a board-certified provider would review your medical history, including your current dosage and treatment duration on your Hims program. It is important to not have a gap in treatment, so plan the transition so your new prescription is ready before your current supply runs out.
Does Hims offer tirzepatide?
Yes. In an April 2026 announcement, Hims said its providers can send prescriptions for brand-name Zepbound vials and Zepbound KwikPen to the LillyDirect pharmacy. Trimi offers both compounded semaglutide and tirzepatide options, which are not FDA-approved, giving patients and their providers flexibility in choosing the medication that best fits their clinical needs and treatment goals.
How long does prescription turnaround take at Hims and Trimi?
Most Trimi patients complete their health assessment and receive a provider evaluation within 12–24 hours, with medication shipping shortly after approval. For Hims' current timelines, check with Hims directly. Actual timelines may vary for both platforms.
Are the providers on Hims and Trimi equally qualified?
Both Hims and Trimi use licensed healthcare providers. Hims operates across several health categories; ask about the credentials of the provider assigned to your weight-loss care. Trimi's providers are board-certified and specifically focused on metabolic health and weight management with GLP-1 medications, which can mean more specialized knowledge in this particular treatment area. Both platforms require providers to be licensed in the patient's state.
Sources & References
- Hims & Hers Health, Inc. Official Website and Weight Loss Program Information. 2026.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- FDA guidance on compounding and the FDA.
- Wegovy prescribing information from the FDA.
- Zepbound prescribing information from the FDA.
- National Association of Boards of Pharmacy. "Compounding Pharmacy Standards and Oversight." 2025.
- American Telemedicine Association. "Telehealth Practice Guidelines." 2025.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and availability information is approximate and subject to change. This article was prepared by the Trimi Medical Team and naturally reflects our perspective, though we have made every effort to present competitor information fairly and accurately.